Asset
ABBV-3373
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03823391 | phase2 | completed | 2019-03-27 | 2020-04-08 | AbbVie | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) |
FDA applications (0)
This company has no applications containing this asset.